Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
EARLIER ACCESS TO INNOVATION: ADAPTIVE LICENSING COMBINED WITH RISK SHARING - INTERIM RESULTS
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Presentation
- By: HOLBEIN, Baerbel (University of Bremen, Duale Hochschule Baden-Württemberg, Germany)
- Co-author(s): Baerbel Holbein: University of Bremen, Duale Hochschule Baden-Württemberg, Bremen, Bad Mergentheim, Germany
BackgroundRisk sharing agreements (RSA) between pharmaceutical companies, health insurers and payers already exist. One crucial question is what a risk sharing model could look like if applied for the clinical trial program with adaptive licensing pathways.
MethodsDrugs recently approved by both FDA and EMA, particularly the new CAR T therapies,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 13 May 2019